Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
暂无分享,去创建一个
Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.
[1] M. Relling,et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype , 2014, Clinical pharmacology and therapeutics.
[2] J. Bautista,et al. G6PD deficiency: the genotype-phenotype association. , 2007, Blood reviews.